Hepion investor holds 10M warrants at $0.06
KI Holdings, Ltd. reports existing direct warrant and indirect common stock holdings in Hepion Pharmaceuticals as a ten percent owner, with no new buy or sell transactions.
Rhea-AI Filing Summary
Hepion Pharmaceuticals, Inc. (HEPA) has a new Form 3 on file from KI Holdings, Ltd., which is reported as a ten percent owner. The filing reports existing positions rather than new trades.
KI Holdings holds warrants directly that are exercisable into 10,000,000 shares of Common Stock at an exercise price of $0.06 per share and expiring on August 3, 2031. It also reports indirect ownership of 10,000,000 shares of Common Stock, with a footnote stating KI Holdings is 100% owned by Kivowitz Investments, Inc., which is owned by Donald Kivowitz.
Positive
- None.
Negative
- None.
Insights
Analyzing...
Insider Trade Summary
2 transactions reported
Mixed
2 txns
Insider
KI Holdings, Ltd.
Role
10% Owner
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| holding | Warrants F1 | -- | -- | -- |
| holding | Common Stock F1 | -- | -- | -- |
Holdings After Transaction:
Warrants — 10,000,000 contracts (Direct);
Common Stock — 10,000,000 shares (Indirect, See Footnote)
Footnotes (1)
- F1. KI Holdings Ltd. is 100% owned by Kivowitz Investments, Inc. which is owned by Donald Kivowitz
Key Figures
Warrant underlying shares: 10,000,000 shares
Warrant exercise price: $0.06 per share
Warrant expiration date: August 3, 2031
+3 more
6 metrics
Warrant underlying shares
10,000,000 shares
Shares of Hepion common stock underlying warrants held directly by KI Holdings, Ltd.
Warrant exercise price
$0.06 per share
Exercise price of Hepion warrants held by KI Holdings, Ltd.
Warrant expiration date
August 3, 2031
Expiration date of the Hepion warrants reported as held by KI Holdings, Ltd.
Indirect common stock holdings
10,000,000 shares
Hepion common stock reported as indirectly owned by KI Holdings, Ltd.
Reporting person status
Ten percent owner
Status of KI Holdings, Ltd. in relation to Hepion Pharmaceuticals, Inc.
Holding entries reported
2 entries
Number of holding entries in the transaction summary
Key Terms
Warrants, Common Stock, ten percent owner, exercise price, +1 more
5 terms
Warrants financial
"KI Holdings holds warrants directly that are exercisable into 10,000,000 shares"
Warrants are special documents that give you the right to buy a company's stock at a set price before a certain date. They are often used as a way for companies to attract investors or raise money, and their value can increase if the company's stock price goes up.
Common Stock financial
"exercisable into 10,000,000 shares of Common Stock at an exercise price"
Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.
ten percent owner regulatory
"KI Holdings, Ltd., which is reported as a ten percent owner"
exercise price financial
"at an exercise price of $0.06 per share and expiring"
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
expiration date financial
"an exercise price of $0.06 per share and expiring on August 3, 2031"
The expiration date is the deadline after which a financial contract, such as an option or a futures agreement, is no longer valid or can be exercised. It matters to investors because it determines the timeframe during which they can take action or benefit from the contract, similar to how a coupon or a food item has a limited period of usefulness. Once the expiration date passes, the contract loses its value or ability to be used.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider position in HEPA does KI Holdings, Ltd. report on this Form 3?
The Form 3 reports that KI Holdings, Ltd. is a ten percent owner of Hepion Pharmaceuticals, Inc. It discloses direct holdings of warrants and indirect holdings of common stock, establishing its status as a significant shareholder.
How many Hepion Pharmaceuticals (HEPA) warrants does KI Holdings, Ltd. hold?
KI Holdings, Ltd. reports direct ownership of warrants exercisable for 10,000,000 shares of Common Stock. These warrants have an exercise price of $0.06 per share and an expiration date of August 3, 2031.
What indirect common stock holdings in HEPA does KI Holdings, Ltd. report?
The Form 3 shows KI Holdings, Ltd. with 10,000,000 shares of Hepion common stock reported as indirectly owned, with the nature of ownership described by a footnote. The footnote explains the ownership chain through Kivowitz Investments, Inc. and Donald Kivowitz.
Are there any buy or sell transactions reported for HEPA in this Form 3?
No. The Form 3 for Hepion Pharmaceuticals, Inc. reports holding entries only, with no acquired or disposed share amounts and no buy or sell transactions shown in the transaction summary.
What does the footnote in the HEPA Form 3 say about KI Holdings, Ltd. ownership?
The footnote states that KI Holdings Ltd. is 100% owned by Kivowitz Investments, Inc., which is owned by Donald Kivowitz. This explains the ownership chain related to the reported indirect holdings of Hepion common stock.
AI-generated analysis. How Rhea-AI works. Not financial advice.
